Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05151315

NitrX Total Knee Arthroplasty RSA

Component Migration, Polyethylene Wear, and Joint Inflammation of the Evolution Versus Evolution NitrX Total Knee Arthroplasty System

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · Academic / Other
Sex
All
Age
21 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Metal hypersensitivity is a recognized complication in some patients following total joint arthroplasty. This can result in a reaction to metal particles from the implants placed in the joint and cause tissue injury. The Evolution® NitrX™ (MicroPort Orthopaedics, Memphis, TN) knee implant was designed with the addition of a coating meant to create a barrier against the release of metal ions. The primary purpose of this study is to compare the Evolution and Evolution NitrX implant (implants your surgeon uses in total knee arthroplasty surgery). This study will compare the stability of these knee implants (any movement the implant makes after surgery) through the use of specialized xrays, called "radiostereometric analysis" (RSA for short). The investigators will also compare levels of circulating metal particles with blood draws and the effects of any circulating metal with MR imaging. The investigators will also be looking at the participants clinical outcomes using joint function and patient satisfaction questionnaires. A total of 50 patients will be enrolled into the study.

Conditions

Interventions

TypeNameDescription
DEVICETotal Knee Arthroplasty with Evolution® NitrX™ Knee SystemPatients will receive cemented Evolution knee system with NitrX coating for their total knee arthroplasty.
DEVICETotal Knee Arthroplasty with Evolution Knee SystemPatients will receive cemented Evolution knee system without NitrX coating for their total knee arthroplasty.

Timeline

Start date
2022-08-01
Primary completion
2025-12-31
Completion
2026-02-28
First posted
2021-12-09
Last updated
2025-03-24

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT05151315. Inclusion in this directory is not an endorsement.